• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [22358 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2015     NIHR Horizon Scanning Centre (NIHR HSC) Palbociclib for advanced or metastatic, oestrogen-receptor positive, HER2-negative, recurrent breast cancer – second line
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal, as well as extraction of relevant recommendations, for a DMP "chronic back pain"]
2015     Belgian Health Care Knowledge Centre (KCE) Bladder cancer: an assessment of international practice guidelines
2015     Agency for Healthcare Research and Quality (AHRQ) Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force
2015     HAYES, Inc. Prosigna Breast Cancer Prognostic Gene Signature Assay
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal, as well as extraction of relevant recommendations, for a DMP "chronic heart failure"]
2015     Belgian Health Care Knowledge Centre (KCE) Comprehensive geriatric care in hospitals: the role of inpatient geriatric consultation teams
2015     Agency for Healthcare Research and Quality (AHRQ) Psychosocial and pharmacologic interventions for disruptive behavior in children and adolescents
2015     HAYES, Inc. Tissue of Origin Test (ResponseDX)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vandetanib (Caprelsa) for locally advanced or metastatic differentiated thyroid cancer – second line
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pertuzumab (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2015     Belgian Health Care Knowledge Centre (KCE) Oncogenetic testing for persons with hereditary endocrine cancer syndromes
2015     Agency for Healthcare Research and Quality (AHRQ) Behavioral programs for diabetes mellitus
2015     HAYES, Inc. Autologous stem cell therapy for treatment of avascular necrosis of the hip
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vemurafenib (Zelboraf) for metastatic BRAF V600 mutation positive melanoma in children and adolescents
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Belatacept: addendum to Commission A15-25]
2015     Belgian Health Care Knowledge Centre (KCE) Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2.
2015     Agency for Healthcare Research and Quality (AHRQ) Screening for speech and language delays and disorders in children age 5 years or younger: a systematic review for the U.S. Preventive Services Task Force
2015     HAYES, Inc. Cryoablation for treatment of non-small cell lung cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) GS-6615 for long QT-3 syndrome
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evolocumab - Benefit assessment according to §35a Social Code Book V]
2015     Belgian Health Care Knowledge Centre (KCE) Gene expression profiling and immunohistochemistry tests for personalised management of adjuvant chemotherapy decisions in early breast cancer – a Rapid Assessment
2015     HAYES, Inc. Full-field digital mammography for breast cancer screening
2015     NIHR Horizon Scanning Centre (NIHR HSC) Holoclar for the treatment of limbal stem cell deficiency due to ocular burns
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab: addendum to Commission A15-27]
2015     Technology Assessment at SickKids (TASK) A cost-effectiveness analysis of maternal genotyping to guide treatment for postpartum pain and avert infant adverse events
2015     Belgian Health Care Knowledge Centre (KCE) Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, LiFraumeni syndrome and Cowden syndrome
2015     Medical Services Advisory Committee (MSAC) The use of Intensity Modulated Radiation Therapy (IMRT) in the treatment of cancer
2015     HAYES, Inc. Intraoperative radiotherapy for treatment of early-stage breast cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) Midodrine (Bramox) for orthostatic hypotension
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sebelipase alfa - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)]
2015     NIHR Health Technology Assessment programme The cost-effectiveness of domiciliary non-invasive ventilation in patients with end-stage chronic obstructive pulmonary disease: a systematic review and economic evaluation
2015     Medical Services Advisory Committee (MSAC) The use of Image Guided Radiation Therapy (IGRT) in the treatment of cancer
2015     HAYES, Inc. Metal-on-metal hip resurfacing arthroplasty versus total hip replacement for osteoarthritis
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tenofovir alafenamide monotherapy for hepatitis B
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Asfotase alfa: assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2015     NIHR Public Health Research (PHR) programme Preventing domestic abuse for children and young people (PEACH): a mixed knowledge scoping review
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Riociguat (Adempas®)
2015     HAYES, Inc. MRI-TRUS fusion-guided biopsy for the diagnosis of prostate cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) Baricitinib for moderate to severe rheumatoid arthritis
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Panobinostat: assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rituximab (MabThera®)
2015     NIHR Health Services and Delivery Research programme Mobilising knowledge to improve UK health care: learning from other countries and other sectors – a multimethod mapping study
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Lisdexamfetamine dimesylate (Elvanse Adult®)
2015     HAYES, Inc. K9 inhibitors for cholesterol reduction: alirocumab and bococizumab
2015     NIHR Horizon Scanning Centre (NIHR HSC) Certolizumab (Cimzia) for early rheumatoid arthritis – first line
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idebenone: assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2015     NIHR Health Technology Assessment programme A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ponatinib (Iclusig®)
2015     NIHR Health Services and Delivery Research programme Contracting with General Dental Services: a mixed-methods study on factors influencing responses to contracts in English general dental practice
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Riociguat (Adempas®)
2015     HAYES, Inc. Peroral Endoscopic Myotomy (POEM) for treatment of esophageal achalasia
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tofacitinib for psoriatic arthritis – second or subsequent line
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pomalidomide: benefit assessment according to §35a Social Code Book V]
2015     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of telephone triage for managing same-day consultation requests in general practice: a cluster randomised controlled trial comparing general practitioner-led and nurse-led management systems with usual care (the ESTEEM trial)
2015     NIHR Health Technology Assessment programme Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer: a systematic review and economic evaluation
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Umeclidinium (Incruse®)
2015     NIHR Health Services and Delivery Research programme The organisation and delivery of health improvement in general practice and primary care: a scoping study
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Enzalutamide (Xtandi®)
2015     HAYES, Inc. Primary endovascular mechanical thrombectomy for treatment of acute ischemic stroke
2015     NIHR Horizon Scanning Centre (NIHR HSC) Patiromer for hyperkalaemia – first line
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Regorafenib: benefit assessment according to §35a Social Code Book V]
2015     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Interventions to improve health-related behaviours of men]
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Leuprorelin acetate (Prostap® SR DCS/Prostap® 3 DCS)
2015     Agency for Healthcare Research and Quality (AHRQ) Treatment of nonmetastatic muscle-invasive bladder cancer
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tacrolimus (Envarsus®)
2015     HAYES, Inc. Second-wave direct-acting antivirals for hepatitis C: Simeprevir
2015     NIHR Horizon Scanning Centre (NIHR HSC) Alectinib for advanced ALK-positive, non-small cell lung cancer – first line
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dabrafenib (new therapeutic indication): benefit assessment according to §35a Social Code Book V]
2015     NIHR Health Technology Assessment programme Evaluating Long-term Outcomes of NHS Stop Smoking Services (ELONS): a prospective cohort study
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Olodaterol (as hydrochloride) (Striverdi® Respimat®)
2015     Agency for Healthcare Research and Quality (AHRQ) Genetic testing for developmental disabilities, intellectual disability, and autism spectrum disorder
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Pomalidomide (Imnovid®)
2015     HAYES, Inc. Sonohysterography for assessment of abnormal uterine bleeding
2015     NIHR Horizon Scanning Centre (NIHR HSC) Alectinib for locally advanced or metastatic ALK-positive, non-small cell lung cancer following failure of crizotinib
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Trametinib: benefit assessment according to §35a Social Code Book V (dossier assessment)]
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Cabozantinib (Cometriq®)
2015     Health Council of the Netherlands Gezondheidsraad (GR) Determining death in postmortal organ donation. Protocols and criteria, including an updated Brain Death Protocol
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Brimonidine (Mirvaso®)
2015     HAYES, Inc. Spinal cord stimulation for relief of neuropathic pain
2015     NIHR Horizon Scanning Centre (NIHR HSC) Atezolizumab for locally advanced or metastatic non-small cell lung cancer – second line
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Follitropin alfa (Bemfola®)
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Beclometasone dipropionate/formoterol fumarate (Fostair®)
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Magnesium aspartate dihydrate (Magnaspartate)
2015     HAYES, Inc. Staged approach to sacral nerve stimulation for treatment of fecal incontinence
2015     NIHR Horizon Scanning Centre (NIHR HSC) Bavituximab for advanced non-small cell lung cancer – second line in combination with docetaxel
2015     NIHR Health Technology Assessment programme Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation
2015     Agency for Healthcare Research and Quality (AHRQ) Relationship between use of quality measures and improved outcomes in serious mental illness
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Lurasidone (Latuda®)
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Brentuximab vedotin (Adcetris®)
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rarunavir/cobicistat (Rezolsta®)
2015     HAYES, Inc. Total pancreatectomy with islet autotransplantation for chronic pancreatitis
2015     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) with erlotinib (Tarceva) for EGFR positive, advanced or metastatic non-small cell lung cancer – first line
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Infliximab (Remsima®)
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Adalimumab (Humira®)
2015     Blue Cross Blue Shield Association (BCBS) Special report: chromosomal microarray for the genetic evaluation of patients with global developmental delay, intellectual disability, and autism spectrum disorder
2015     NIHR Horizon Scanning Centre (NIHR HSC) Dabrafenib (Tafinlar) and trametinib (Mekinist) combination therapy for metastatic BRAF V600E positive non-small cell lung cancer
2015     NIHR Health Technology Assessment programme Surgical Trial In Traumatic intraCerebral Haemorrhage (STITCH): a randomised controlled trial of Early Surgery compared with Initial Conservative Treatment
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Infliximab (Inflectra®)
2015     NIHR Health Technology Assessment programme LDK378 for previously treated anaplastic-lymphoma-kinase-positive non-small-cell lung cancer [ID729]